Haldol and Mcp drug interactions - from FDA reports

Summary

Drug interactions are reported only by a few people who take Haldol and Mcp together. This review analyzes the effectiveness and drug interactions between Haldol and Mcp. It is created by eHealthMe based on reports of 5 people who take the same drugs from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on haloperidol and pectin (the active ingredients of Haldol and Mcp, respectively), and Haldol and Mcp (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Haldol?

Haldol has active ingredients of haloperidol. It is often used in schizophrenia. (latest outcomes from Haldol 18,078 users)

What is Mcp?

Mcp has active ingredients of pectin. (latest outcomes from Mcp 931 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 14, 2019

5 people who take Haldol, Mcp are studied.


Number of reports submitted per year:

Haldol and Mcp drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
  2. Blood calcium decreased
  3. Fall
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. General physical health deterioration (weak health status)
  6. Haemoglobin decreased
  7. Herpes virus infection
  8. Leukopenia (less number of white blood cells in blood)
  9. Loss of control of legs
  10. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  2. Hypotension (abnormally low blood pressure)
  3. Osteonecrosis of jaw (death of bone of jaw)
  4. Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
  5. Blood calcium decreased
  6. Blood glucose increased
  7. Blood potassium decreased
  8. Blood uric acid increased
  9. C-reactive protein increased
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

Most common drug interactions by gender *:

female:
  1. Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
  2. Dyspnoea (difficult or laboured respiration)
  3. Fall
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. General physical health deterioration (weak health status)
  6. Haemoglobin decreased
  7. Herpes virus infection
  8. Leukopenia (less number of white blood cells in blood)
  9. Loss of control of legs
  10. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
male:
  1. Osteonecrosis of jaw (death of bone of jaw)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:
  1. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  2. Hypotension (abnormally low blood pressure)
  3. Osteonecrosis of jaw (death of bone of jaw)
60+:

n/a

* Approximation only. Some reports may have incomplete information.


Do you take Haldol and Mcp?

You are not alone:




Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Haldol and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Mcp and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Haldol and Mcp
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Haldol and Mcp



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.